VTYX - Ventyx Biosciences, Inc. Stock Price, Fair Value and News

$2.01-0.04 (-1.95%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

VTYX Price Action

Last 7 days

-10.7%


Last 30 days

-8.2%


Last 90 days

-6.5%


Trailing 12 Months

-10.3%

VTYX Stock Price

Mar'24Jun'24Sep'24Dec'240246810
$2.01

VTYX RSI Chart

MayJunJulAugSepOctNovDec202501020304050607080

VTYX Valuation

Market Cap

142.1M

Price/Earnings (Trailing)

-0.93

Price/Free Cashflow

-0.89

VTYX Price/Earnings (Trailing)

2022202320242025-40-30-20-100

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

VTYX Fundamentals

VTYX Earnings

Earnings (TTM)

-152.5M

Earnings Growth (Yr)

34.76%

Earnings Growth (Qtr)

-10.33%

2021202220232024-200M-150M-100M-50M

VTYX Profitability

Return on Equity

-54.71%

Return on Assets

-50.66%

Free Cashflow Yield

-112.38%

VTYX Investor Care

Shares Dilution (1Y)

19.75%

Diluted EPS (TTM)

-2.36

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Its lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.
 CEO
 WEBSITEhttps://ventyxbio.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES91

Ventyx Biosciences, Inc. Frequently Asked Questions


What is the ticker symbol for Ventyx Biosciences, Inc.? What does VTYX stand for in stocks?

VTYX is the stock ticker symbol of Ventyx Biosciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Ventyx Biosciences, Inc. (VTYX)?

As of Fri Jan 31 2025, market cap of Ventyx Biosciences, Inc. is 142.13 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VTYX stock?

You can check VTYX's fair value in chart for subscribers.

Is Ventyx Biosciences, Inc. a good stock to buy?

The fair value guage provides a quick view whether VTYX is over valued or under valued. Whether Ventyx Biosciences, Inc. is cheap or expensive depends on the assumptions which impact Ventyx Biosciences, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VTYX.